163 related articles for article (PubMed ID: 25173391)
21. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
[TBL] [Abstract][Full Text] [Related]
22. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior.
Park S; Kim E; Koh SE; Maeng S; Lee WD; Lim J; Shim I; Lee YJ
Brain Res; 2012 Jul; 1466():158-66. PubMed ID: 22634376
[TBL] [Abstract][Full Text] [Related]
23. In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation.
Papanikolaou T; Amano T; Lennington J; Sink K; Farrar AM; Salamone J; Yang X; Conover JC
Eur J Neurosci; 2009 Jun; 29(12):2264-75. PubMed ID: 19508691
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Parkinson's disease using cell transplantation.
Lindvall O
Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140370. PubMed ID: 26416681
[TBL] [Abstract][Full Text] [Related]
25. Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment.
Ganat YM; Calder EL; Kriks S; Nelander J; Tu EY; Jia F; Battista D; Harrison N; Parmar M; Tomishima MJ; Rutishauser U; Studer L
J Clin Invest; 2012 Aug; 122(8):2928-39. PubMed ID: 22751106
[TBL] [Abstract][Full Text] [Related]
26. Understanding Parkinson's Disease through the Use of Cell Reprogramming.
Playne R; Connor B
Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784
[TBL] [Abstract][Full Text] [Related]
27. Reducing glypican-4 in ES cells improves recovery in a rat model of Parkinson's disease by increasing the production of dopaminergic neurons and decreasing teratoma formation.
Fico A; de Chevigny A; Melon C; Bohic M; Kerkerian-Le Goff L; Maina F; Dono R; Cremer H
J Neurosci; 2014 Jun; 34(24):8318-23. PubMed ID: 24920634
[TBL] [Abstract][Full Text] [Related]
28. Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.
Qiu L; Liao MC; Chen AK; Wei S; Xie S; Reuveny S; Zhou ZD; Hunziker W; Tan EK; Oh SKW; Zeng L
Stem Cells Transl Med; 2017 Sep; 6(9):1803-1814. PubMed ID: 28650520
[TBL] [Abstract][Full Text] [Related]
29. Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease.
Doi D; Magotani H; Kikuchi T; Ikeda M; Hiramatsu S; Yoshida K; Amano N; Nomura M; Umekage M; Morizane A; Takahashi J
Nat Commun; 2020 Jul; 11(1):3369. PubMed ID: 32632153
[TBL] [Abstract][Full Text] [Related]
30. Neural stem cells and transplantation studies in Parkinson's disease.
Pardal R; López-Barneo J
Adv Exp Med Biol; 2012; 741():206-16. PubMed ID: 22457112
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of polysialic acid expression improves function of embryonic stem-derived dopamine neuron grafts in Parkinsonian mice.
Battista D; Ganat Y; El Maarouf A; Studer L; Rutishauser U
Stem Cells Transl Med; 2014 Jan; 3(1):108-13. PubMed ID: 24311700
[TBL] [Abstract][Full Text] [Related]
32. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.
Kriks S; Shim JW; Piao J; Ganat YM; Wakeman DR; Xie Z; Carrillo-Reid L; Auyeung G; Antonacci C; Buch A; Yang L; Beal MF; Surmeier DJ; Kordower JH; Tabar V; Studer L
Nature; 2011 Nov; 480(7378):547-51. PubMed ID: 22056989
[TBL] [Abstract][Full Text] [Related]
33. The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
Luk KC; Rymar VV; van den Munckhof P; Nicolau S; Steriade C; Bifsha P; Drouin J; Sadikot AF
J Neurochem; 2013 Jun; 125(6):932-43. PubMed ID: 23331067
[TBL] [Abstract][Full Text] [Related]
34. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
35. Clinical translation of stem cell transplantation in Parkinson's disease.
Lindvall O
J Intern Med; 2016 Jan; 279(1):30-40. PubMed ID: 26332959
[TBL] [Abstract][Full Text] [Related]
36. Neural stem cells transplanted in a mouse model of Parkinson's disease differentiate to neuronal phenotypes and reduce rotational deficit.
Ziavra D; Makri G; Giompres P; Taraviras S; Thomaidou D; Matsas R; Mitsacos A; Kouvelas ED
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):829-35. PubMed ID: 23131156
[TBL] [Abstract][Full Text] [Related]
37. Combined MSC-Secreted Factors and Neural Stem Cell Transplantation Promote Functional Recovery of PD Rats.
Yao Y; Huang C; Gu P; Wen T
Cell Transplant; 2016; 25(6):1101-13. PubMed ID: 26607204
[TBL] [Abstract][Full Text] [Related]
38. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.
Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP
EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421
[TBL] [Abstract][Full Text] [Related]
39. Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).
Ramos-Moreno T; Castillo CG; Martínez-Serrano A
Behav Brain Res; 2012 Jun; 232(1):225-32. PubMed ID: 22537773
[TBL] [Abstract][Full Text] [Related]
40. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
Pan-Montojo F; Funk RH
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
